SCHEMBL7423461

SCHEMBL7423461

COc1ccc(S(=O)(=O)NCC(NS(=O)(=O)c2c(C)cc(C)cc2C)C(=O)NO)cc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP7 P09237 3/20 0.58
MMP9 P14780 2/20 0.52
MMP10 P09238 1/20 0.52
ALDH1A1 P00352 4/20 0.50
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRA3 P34903 1/20 0.48
FFAR4 Q5NUL3 1/20 0.48
RAPGEF4 Q8WZA2 1/20 0.47
BMP1 P13497 6/20 0.47
MEP1B Q16820 1/20 0.46
MMP13 P45452 2/20 0.46
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
MMP1 P03956 1/20 0.45
MMP2 P08253 1/20 0.45
MMP8 P22894 1/20 0.45
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7416682 0.96 MMP7 (0.58) MMP7MMP9MMP10ALDH1A1GABRG2
SCHEMBL7419926 0.88 MMP7 (0.60) MMP7MMP9MMP10ALDH1A1BMP1
SCHEMBL7417246 0.88 MMP7 (0.65) MMP7MMP9MMP10ALDH1A1BMP1
SCHEMBL7414547 0.87 MMP7 (0.54) MMP7MMP9MMP10FFAR4BMP1
SCHEMBL7412866 0.86 MMP7 (0.61) MMP7MMP9MMP10ALDH1A1MMP13
SCHEMBL7418672 0.85 MMP9 (0.57) MMP7MMP9MMP10ALDH1A1MMP13
SCHEMBL7413136 0.85 MMP9 (0.53) MMP7MMP9MMP10MMP13CA1
SCHEMBL7411120 0.83 MMP7 (0.54) MMP7MMP9MMP10FFAR4BMP1
SCHEMBL7415839 0.83 MMP7 (0.66) MMP7MMP9MMP10ALDH1A1BMP1
SCHEMBL7414877 0.83 MMP7 (0.66) MMP7MMP9MMP10ALDH1A1BMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed